Statistics

Total Visits

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients61

Select a period of time:

Number of views in the range

Views
cost-saving approach to triple therapy for hepatitis C using the OPTIM prognostic tool to predict virologic response to 4 weeks of peginterferon and ribavirin in genotype 1 patients18

Views

Views
August 20251
September 20256
October 20252
November 20257
December 20252
January 20260
February 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
Brazil4
United Kingdom3
Argentina3
Peru1
 

Top cities views

Views
Dallas6
Buenos Aires1
Catamarca1
Comas1
Ezeiza1
Itabaianinha1
Jaraguá1
João Pessoa1
Porto Alegre1